Recruiting studies: Apheresis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Spec
Phase N/A · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00067054 Apheresis of Patients With Immunodeficiency
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01212055 SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Phase 1 · 3 location(s) · St. Jude Children's Research Hospital · NCT06442761 Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
Phase 3 · 33 location(s) · Mayo Clinic · NCT07100990 CRP Apheresis in STEMI
NA · 5 location(s) · Medical University Innsbruck · NCT04939805 Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001405 Gene Editing For Sickle Cell Disease
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT06506461 Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT02682667 Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Phase N/A · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT00001846 Improving White Blood Cell Collection From Healthy Donors
Phase 4 · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT01553214 APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer
NA · 1 location(s) · Umeå University · NCT06709326 Apheresis Collection for New Drug Development and Evaluation Research
Phase N/A · 2 location(s) · TCRx Therapeutics Co.Ltd · NCT07663565 Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
NA · 1 location(s) · Kaneka Medical America LLC · NCT02952144 grouP O wholE blooD : storagE leSion impacT And infLammation
NA · 1 location(s) · Etablissement Français du Sang · NCT06809010 Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00114647 Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Phase N/A · 16 location(s) · A2 Biotherapeutics Inc. · NCT04981119 PET Imaging and Lymph Node Assessment of IRIS in People With AIDS
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02147405 Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06399107 NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05189925 Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001529 Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Partic
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06414889 Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01087333 New Therapeutic Strategy Against Preeclampsia
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06464159 Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00029445

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.